Stockholm - Delayed Quote SEK

Prostatype Genomics AB (publ) (PROGEN.ST)

Compare
9.10
+0.40
+(4.60%)
At close: January 31 at 5:01:11 PM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-33,149.00
-29,138.00
-27,693.00
-16,078.21
Investing Cash Flow
-14,297.00
-8,566.00
--
-2,499.64
Financing Cash Flow
37,242.00
28,911.00
18,853.00
23,045.24
End Cash Position
1,768.00
2,682.00
11,489.00
20,329.18
Capital Expenditure
-14,289.00
-8,562.00
--
-2,499.64
Issuance of Debt
38,136.00
34,311.00
19,253.00
23,245.24
Repayment of Debt
-9,600.00
-5,400.00
-400.00
-200.00
Free Cash Flow
-47,438.00
-37,700.00
-27,693.00
-18,577.85
12/31/2021 - 11/3/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade